EGFR and glioblastoma: The presence of any one of the following five features is sufficient to classify an IDH-wildtype diffuse astrocytic glioma as a GBM: microvascular proliferation, necrosis, TERT promoter mutation, EGFR gene amplification, or combined whole chromosome 7 gain and 10 loss (+7/−10).